Concepedia

Rina Fong

RF

13

Publications

2.2K

Citations

12

H-Index

2009

Active since

Affiliations

Research & Diagnostic Antibodies (United States)(Current)

Gilead Sciences (United States)

Rina Fong is an author at Research & Diagnostic Antibodies (United States) specializing in medicine, tumor biology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2009–2024

13

Publications

13

Novel antibody–antibiotic conjugate eliminates intracellular S. aureus

Sophie M. Lehar, Thomas H. Pillow, Min Xu et al. · Nature · 2015 · 815 citations

, , +7

Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability

Benjamin Lauffer, Robert Mintzer, Rina Fong et al. · Journal of Biological Chemistry · 2013 · 400 citations · Full text

An In Vivo Human-Plasmablast Enrichment Technique Allows Rapid Identification of Therapeutic Influenza A Antibodies

Gerald Nakamura, Ning Chai, Summer Park et al. · Cell Host & Microbe · 2013 · 175 citations · Full text

, , +7

An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance

Thijs J. Hagenbeek, Marc Hafner, Rana Mroue et al. · Nature Cancer · 2023 · 169 citations · Full text

Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling

Jeffrey K. Holden, James J. Crawford, Cameron L. Noland et al. · Cell Reports · 2020 · 160 citations · Full text

, , +17

Rows per page

1–5 of 13